COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management

Yasar Sattar1, Waqas Ullah2, Hiba Rauf3

  • 1Internal Medicine, Icahn School of Medicine at Mount Sinai - Elmhurst Hospital, NY, USA.

Insights

Coronavirus Disease 2019 (COVID-19) causes various cardiac issues, especially in those with prior heart conditions. This review covers COVID-19

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathophysiology

Background:

  • Coronavirus Disease 2019 (COVID-19) is a global pandemic.
  • Cardiovascular manifestations are common in COVID-19 patients.
  • Pre-existing cardiac conditions exacerbate COVID-19's cardiac effects.

Purpose of the Study:

  • To review the cellular pathophysiology of cardiac manifestations in COVID-19.
  • To outline the clinical presentations of cardiac involvement in COVID-19.
  • To discuss treatment strategies for COVID-19-related cardiac conditions.

Main Methods:

  • Literature review of cellular pathophysiology.
  • Analysis of clinical manifestations.
  • Summary of current treatment modalities.

Main Results:

  • COVID-19 can lead to myocardial injury, infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest.
  • Patients with coronary artery disease, hypertension, diabetes, and coagulation disorders face worse outcomes.
  • Advanced age and immunocompromised states are significant risk factors.

Conclusions:

  • Understanding the pathophysiology is crucial for managing cardiac complications.
  • Early recognition and tailored treatment are essential for improving patient outcomes.
  • Multidisciplinary approaches are needed to address the complex cardiac sequelae of COVID-19.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
277
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
222
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
100
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
132
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
261